Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

First-in-human phase I trial combining radiopharmaceutical therapy (RPT) using a 90y-anti-CD25 monoclonal antibody (Mab) with total marrow and lymphoid irradiation (TMLI) in relapsed or refractory (R/R) acute leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJeffrey WongMMMonzr M. Al MalkiVAVikram Adhikarla

Discussion

Loading...

Member takes

Overview

Phase I trial determines maximum tolerated dose of 90Y-anti-CD25 Mab in relapsed acute leukemia, suggesting potential for improved outcomes.

Key Points

  • All patients achieved complete remission after treatment with 90Y-anti-CD25 Mab and TMLI.
  • The maximum tolerated dose of 90Y-anti-CD25 Mab was evaluated in older patients with relapsed acute leukemia.
  • This approach demonstrated favorable pharmacokinetics, targeting bone marrow and spleen effectively.
  • Further trials are needed to explore the full potential of combining RPT and TMLI for acute leukemia treatment.

Cite This Study

Wong et al. (2025) studied this question.

synapsesocial.com/papers/69362f7d4fa91c937236e4bbhttps://doi.org/10.1182/blood-2025-508
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Total marrow and lymphoid irradiation (TMLI) with fludarabine-melphalan (FM) conditioning for matched donor hematopoietic cell transplant (HCT) in older patients with Relapsed/Refractory (R/R) disease2025
  2. 2Total marrow and lymphoid irradiation (2000 cGy) together with cyclophosphamide and etoposide prior to allogeneic hematopoietic cell transplantation is an effective regimen for Relapsed/Refractory leukemia, with low non-relapse mortality2025
  3. 3Safety of myeloablative total marrow and lymphoid irradiation versus chemotherapy-based conditioning in adults with high-risk acute lymphoblastic leukemia in a limited resources setting2025
  4. 4Safety and feasibility of outpatient myeloablative total marrow and lymphoid Irradiation–based allogeneic transplantation in adults with high-risk acute lymphoblastic leukemia2025
  5. 5At-211-anti-CD45 radioimmunotherapy as conditioning prior to haploidentical hematopoietic cell transplantation in mouse models2025